<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31747940</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>21</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>01</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1472-6882</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>19</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Nov</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>BMC complementary and alternative medicine</Title>
          <ISOAbbreviation>BMC Complement Altern Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Qingkailing injection ameliorates cerebral ischemia-reperfusion injury and modulates the AMPK/NLRP3 Inflammasome Signalling pathway.</ArticleTitle>
        <Pagination>
          <StartPage>320</StartPage>
          <MedlinePgn>320</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">320</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12906-019-2703-5</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cerebral ischemia is the second-leading cause of death and the main cause of permanent adult disabilities worldwide. Qingkailing (QKL) injection, a patented Chinese medicine approved by the China Food and Drug Administration, has been widely used in clinical practice to treat cerebral ischemia in China. The NOD-like receptor pyrin 3 (NLRP3) inflammasome is activated in cerebral ischemia and thus, is an effective therapeutic target. AMP-activated protein kinase (AMPK) is an important regulator inhibiting NLRP3 inflammasome activation.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We investigated the potential of QKL injection to provide neuroprotection after cerebral ischemia in a rat model of middle cerebral artery occlusion (MCAO). Adult male Sprague-Dawley rats (210-230 g) were randomly divided into three groups which consist of sham, MCAO and 3 ml/kg QKL. Rats in the QKL group received intraperitoneal injections of 3 ml/kg QKL, while rats in other groups were given saline in the same volumes. After 90 min ischemia and 24 h reperfusion, neurological function, laser speckle imaging, brain infarction, brain water content and brain blood barrier permeability were examined and cell apoptosis at prefrontal cortex were evaluated 24 h after MCAO, and western blot and real-time quantitative polymerase chain reaction was also researched, respectively.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Intraperitoneal administration of QKL alleviated neurological deficiencies, cerebral infarction, blood-brain barrier permeability, brain oedema and brain cell apoptosis after MCAO induction. QKL decreased pro-inflammatory cytokines, TNF-α, IL-6 and IL-1β, and increased anti-inflammatory cytokines, IL-4 and IL-10. Furthermore, QKL activated phosphorylated AMPK, decreased oxidative stress and decreased NLRP3 inflammasome activation.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">QKL relieved cerebral ischemia reperfusion injury and suppressed the inflammatory response by inhibiting AMPK-mediated activation of the NLRP3 inflammasome. These results suggest that QKL might have potential in treating brain inflammatory response and attenuating the cerebral ischemia-reperfusion injury.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>Chongyang</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>School of Traditional Chinese Medicine, Capital Medical University, 10 Youanmenwai, Xitoutiao, Fengtai District, Beijing, 100069, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Traditional Chinese Medicine Department, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chao Yang District, Beijing, 100029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Xueqian</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>School of Traditional Chinese Medicine Department, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chao Yang District, Beijing, 100029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Tian</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>School of Traditional Chinese Medicine Department, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chao Yang District, Beijing, 100029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Xue</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>School of Traditional Chinese Medicine Department, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chao Yang District, Beijing, 100029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Shuang</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>School of Traditional Chinese Medicine Department, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chao Yang District, Beijing, 100029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Shuling</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>School of Traditional Chinese Medicine Department, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chao Yang District, Beijing, 100029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gao</LastName>
            <ForeName>Yushan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>School of Traditional Chinese Medicine Department, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chao Yang District, Beijing, 100029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fan</LastName>
            <ForeName>Shuning</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>School of Traditional Chinese Medicine Department, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chao Yang District, Beijing, 100029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Changxiang</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>School of Traditional Chinese Medicine Department, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chao Yang District, Beijing, 100029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhai</LastName>
            <ForeName>Changming</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>School of Traditional Chinese Medicine Department, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chao Yang District, Beijing, 100029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cheng</LastName>
            <ForeName>Fafeng</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>School of Traditional Chinese Medicine Department, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chao Yang District, Beijing, 100029, China. fafengcheng@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Qingguo</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>School of Traditional Chinese Medicine Department, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chao Yang District, Beijing, 100029, China. wangqg8558@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>BMC Complement Altern Med</MedlineTA>
        <NlmUniqueID>101088661</NlmUniqueID>
        <ISSNLinking>1472-6882</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004365">Drugs, Chinese Herbal</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D058847">Inflammasomes</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000071199">NLR Family, Pyrin Domain-Containing 3 Protein</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C573346">Nlrp3 protein, rat</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C504928">Qingkailing</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.31</RegistryNumber>
          <NameOfSubstance UI="D055372">AMP-Activated Protein Kinases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D055372" MajorTopicYN="N">AMP-Activated Protein Kinases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001812" MajorTopicYN="N">Blood-Brain Barrier</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002545" MajorTopicYN="N">Brain Ischemia</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004365" MajorTopicYN="N">Drugs, Chinese Herbal</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058847" MajorTopicYN="N">Inflammasomes</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071199" MajorTopicYN="N">NLR Family, Pyrin Domain-Containing 3 Protein</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015427" MajorTopicYN="N">Reperfusion Injury</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cerebral ischemia-reperfusion injury</Keyword>
        <Keyword MajorTopicYN="N">Chinese medicine</Keyword>
        <Keyword MajorTopicYN="N">NLRP3 inflammasome</Keyword>
        <Keyword MajorTopicYN="N">Qingkailing injection</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>11</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31747940</ArticleId>
        <ArticleId IdType="pmc">PMC6868863</ArticleId>
        <ArticleId IdType="doi">10.1186/s12906-019-2703-5</ArticleId>
        <ArticleId IdType="pii">10.1186/s12906-019-2703-5</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Feigin VL, Krishnamurthi RV, Parmar P, Norrving B, Mensah GA, Bennett DA, Barker-Collo S, Moran AE, Sacco RL, Truelsen T. Update on the global burden of ischemic and hemorrhagic stroke in 1990-2013: the GBD 2013 study. Neuroepidemiology. 2015;45(3):161–176. doi: 10.1159/000441085.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000441085</ArticleId>
            <ArticleId IdType="pmc">PMC4633282</ArticleId>
            <ArticleId IdType="pubmed">26505981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, Floyd J, Fornage M, Gillespie C, Isasi C. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–e603. doi: 10.1161/CIR.0000000000000485.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIR.0000000000000485</ArticleId>
            <ArticleId IdType="pmc">PMC5408160</ArticleId>
            <ArticleId IdType="pubmed">28122885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Powers W, Rabinstein A, Ackerson T, Adeoye O, Bambakidis N, Becker K, Biller J, Brown M, Demaerschalk B, Hoh B. 2018 guidelines for the early management of patients with acute ischemic stroke. Stroke. 2018;49(3):e46-e97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29367334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang J, Wang T, Yu D, Fang X, Fan H, Liu Q, Yi G, Yi X, Liu Q. l-Homocarnosine attenuates inflammation in cerebral ischemia–reperfusion injury through inhibition of nod-like receptor protein 3 inflammasome. Int J Biol Macromol. 2018;118:357-64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29890246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cai W, Zhang K, Li P, Zhu L, Xu J, Yang B, Hu X, Lu Z, Chen J. Dysfunction of the neurovascular unit in ischemic stroke and neurodegenerative diseases: an aging effect. Ageing Res Rev. 2017;34:77–87. doi: 10.1016/j.arr.2016.09.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.arr.2016.09.006</ArticleId>
            <ArticleId IdType="pmc">PMC5384332</ArticleId>
            <ArticleId IdType="pubmed">27697546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoseini Z, Sepahvand F, Rashidi B, Sahebkar A, Masoudifar A, Mirzaei H. NLRP3 inflammasome: its regulation and involvement in atherosclerosis. J Cell Physiol. 2018;233(3):2116-32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28345767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elliott EI, Sutterwala FS. Initiation and perpetuation of NLRP3 inflammasome activation and assembly. Immunol Rev. 2015;265(1):35–52. doi: 10.1111/imr.12286.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/imr.12286</ArticleId>
            <ArticleId IdType="pmc">PMC4400874</ArticleId>
            <ArticleId IdType="pubmed">25879282</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kanneganti T-D. Inflammatory bowel disease and the NLRP3 Inflammasome. N Engl J Med. 2017;377(7):694–696. doi: 10.1056/NEJMcibr1706536.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMcibr1706536</ArticleId>
            <ArticleId IdType="pubmed">28813221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fann DY-W, Lee S, Manzanero S, Tang S, Gelderblom M, Chunduri P, Bernreuther C, Glatzel M, Cheng Y, Thundyil J. Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke. Cell Death Dis. 2013;4(9):e790. doi: 10.1038/cddis.2013.326.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cddis.2013.326</ArticleId>
            <ArticleId IdType="pmc">PMC3789184</ArticleId>
            <ArticleId IdType="pubmed">24008734</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong Y, Fan C, Hu W, Jiang S, Ma Z, Yan X, Deng C, Di S, Xin Z, Wu G. Melatonin attenuated early brain injury induced by subarachnoid hemorrhage via regulating NLRP3 inflammasome and apoptosis signaling. J Pineal Res. 2016;60(3):253–262. doi: 10.1111/jpi.12300.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jpi.12300</ArticleId>
            <ArticleId IdType="pubmed">26639408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang F, Wang Z, Wei X, Han H, Meng X, Zhang Y, Shi W, Li F, Xin T, Pang Q. NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke. J Cereb Blood Flow Metab. 2014;34(4):660–667. doi: 10.1038/jcbfm.2013.242.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/jcbfm.2013.242</ArticleId>
            <ArticleId IdType="pmc">PMC3982086</ArticleId>
            <ArticleId IdType="pubmed">24424382</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Day E A, Ford R J, Steinberg G R. AMPK as a therapeutic target for treating metabolic diseases[J]. Trends in Endocrinol Metab. 2017;28(8):545-60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28647324</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cordero MD, Williams MR, Ryffel B. AMP-activated protein kinase regulation of the NLRP3 inflammasome during aging[J]. Trends inEndocrinol Metab. 2018;29(1):8-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29150317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shen P, Hou S, Zhu M, Zhao M, Ouyang Y, Feng J. Cortical spreading depression preconditioning mediates neuroprotection against ischemic stroke byinducing AMP-activated protein kinase-dependent autophagy in a rat cerebral ischemic/reperfusion injury model. J Neurochem. 2017;140(5):799-813.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27987215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Medicine BUoC: The study of novel dosage form of an Gong Niu Huang wan. J New Med 1975, 8(12):12–13.</Citation>
        </Reference>
        <Reference>
          <Citation>Sun Liangming CF, Xueqian W, Qingguo W. A systematic review and Meta -analysis of Qingkailing injection on acute stroke. Zhongguo Zhongyi Jizheng. 2016;25(5):772–776.</Citation>
        </Reference>
        <Reference>
          <Citation>Cheng F, Wang X, Lu Y, Zhong X, Zhao Y, Wang Q. Chinese medicine injection qingkailing for treatment of acute ischemia stroke: a systematicreview of randomized controlled trials[J]. Evid Based Complement Alternat Med. 2012;2012, Article ID 213172:7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3364691</ArticleId>
            <ArticleId IdType="pubmed">22675376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang G, Xie Y, Wang L, Wang Q, Jia P, Feng B. Analysis of drug combination characteristics of Qingkailing injection for treating abnormal inflammatory factors in real world. China J Chinese Materia Medica. 2017;42(10):1984–1990.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29090561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mana L, Wang S, Zhu H, Xing Y, Lou L, Wu A, Dong B, Sun Y, Yang S, Wang L. Qingkailing Suppresses the Activation of BV2 Microglial Cells by Inhibiting Hypoxia/Reoxygenation-Induced Inflammatory Responses. Evidence-Based Complementray Alternative Med. 2014;2014(1):696218.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4020462</ArticleId>
            <ArticleId IdType="pubmed">24864157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng Y, Hou J, Liu J, Yao M, Li L, Zhang B, Zhu H, Wang Z. Inhibition of autophagy contributes to melatonin-mediated neuroprotection against transient focal cerebral ischemia in rats. J Pharmacol Sci. 2014;124(3):354–364. doi: 10.1254/jphs.13220FP.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1254/jphs.13220FP</ArticleId>
            <ArticleId IdType="pubmed">24646622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20(1):84–91. doi: 10.1161/01.STR.20.1.84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.STR.20.1.84</ArticleId>
            <ArticleId IdType="pubmed">2643202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beker MC, Caglayan AB, Kelestemur T, Caglayan B, Yalcin E, Yulug B, Kilic U, Hermann DM, Kilic E. Effects of normobaric oxygen and melatonin on reperfusion injury: role of cerebral microcirculation. Oncotarget. 2015;6(31):30604–30614. doi: 10.18632/oncotarget.5773.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.5773</ArticleId>
            <ArticleId IdType="pmc">PMC4741555</ArticleId>
            <ArticleId IdType="pubmed">26416428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang W, Ma X, Han J, Zhou M, Ren H, Pan Q, Zheng C, Zheng Q. Neuroprotective effect of Scutellarin on ischemic cerebral injury by Down-regulating the expression of angiotensin-converting enzyme and AT1 receptor. PLoS One. 2016;11(1):e0146197. doi: 10.1371/journal.pone.0146197.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0146197</ArticleId>
            <ArticleId IdType="pmc">PMC4711585</ArticleId>
            <ArticleId IdType="pubmed">26730961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen B, Wang G, Li W, Liu W, Lin R, Tao J, Jiang M, Chen L, Wang Y. Memantine attenuates cell apoptosis by suppressing the Calpain-Caspase-3 pathway in an experimental model of ischemic stroke. Exp Cell Res. 2017;351(2):163–172. doi: 10.1016/j.yexcr.2016.12.028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yexcr.2016.12.028</ArticleId>
            <ArticleId IdType="pubmed">28069373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng F, Zhong X, Lu Y, Wang X, Song W, Guo S, Wang X, Liu D, Wang Q. Refined Qingkailing protects MCAO mice from endoplasmic reticulum stress-induced apoptosis with a broad time window. Evid Based Complement Alternat Med. 2012;2012 Article ID567872:12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3320064</ArticleId>
            <ArticleId IdType="pubmed">22536287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poinsatte K, Selvaraj UM, Ortega SB, Plautz EJ, Kong X, Gidday JM, Stowe AM. Quantification of neurovascular protection following repetitive hypoxic preconditioning and transient middle cerebral artery occlusion in mice. J Vis Exp Jove. 2015;379(99):e52675.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4541629</ArticleId>
            <ArticleId IdType="pubmed">25993394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oh TW, Park KH, Jung HW, Park YK. Neuroprotective effect of the hairy root extract of Angelica gigas NAKAI on transient focal cerebral ischemia in rats through the regulation of angiogenesis. BMC Complement Altern Med. 2015;15(1):1–11. doi: 10.1186/s12906-015-0520-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12906-015-0520-z</ArticleId>
            <ArticleId IdType="pmc">PMC4392731</ArticleId>
            <ArticleId IdType="pubmed">25888524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu MW, Wei R, Su MX, Li H, Fang TW, Zhang W. Effects of Panax notoginseng saponins on severe acute pancreatitis through the regulation of mTOR/Akt and caspase-3 signaling pathway by upregulating miR-181b expression in rats. BMC Complement Altern Med. 2018;18(1):51. doi: 10.1186/s12906-018-2118-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12906-018-2118-8</ArticleId>
            <ArticleId IdType="pmc">PMC5800027</ArticleId>
            <ArticleId IdType="pubmed">29402262</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu S, Zhong A, Ma H, Li D, Hu Y, Xu Y, Zhang J. Neuroprotective effect of salvianolic acid B against cerebral ischemic injury in rats via the CD40/NF-Î°B pathway associated with suppression of platelets activation and neuroinflammation. Brain Res. 2017:1661, 37–48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28214521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng F, Ma C, Wang X, Zhai C, Wang G, Xu X, Mu J, Li C, Wang Z, Zhang X. Effect of traditional Chinese medicine formula Sinisan on chronic restraint stress-induced nonalcoholic fatty liver disease: a rat study. BMC Complement Alternat Med. 2017;17(1):203. doi: 10.1186/s12906-017-1707-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12906-017-1707-2</ArticleId>
            <ArticleId IdType="pmc">PMC5383977</ArticleId>
            <ArticleId IdType="pubmed">28388904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Z, Qin L, Peng L, Zhang Q, Wang Q, Lu Z, Song Y, Gao X. Pharmacokinetic-pharmacodynamic modeling to study the antipyretic effect of Qingkailing injection on pyrexia model rats. Molecules. 2016;21(3):317. doi: 10.3390/molecules21030317.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules21030317</ArticleId>
            <ArticleId IdType="pmc">PMC6273305</ArticleId>
            <ArticleId IdType="pubmed">26959005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ismael S, Zhao L, Nasoohi S, Ishrat T. Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke. Sci Rep. 2018;8(1):5971. doi: 10.1038/s41598-018-24350-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-018-24350-x</ArticleId>
            <ArticleId IdType="pmc">PMC5899150</ArticleId>
            <ArticleId IdType="pubmed">29654318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim MJ, Kim EH, Pun NT, Chang J-H, Kim J, Jeong J-H, Choi DY, Kim S-H, Park P-H. Globular adiponectin inhibits lipopolysaccharide-primed inflammasomes activation in macrophages via autophagy induction: the critical role of AMPK signaling. Int J Mol Sci. 2017;18(6):1275. doi: 10.3390/ijms18061275.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms18061275</ArticleId>
            <ArticleId IdType="pmc">PMC5486097</ArticleId>
            <ArticleId IdType="pubmed">28617316</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang S, Li T, Ji T, Yi W, Gu C. AMPK: potential therapeutic target for ischemic stroke. Theranostics. 2018;8(16):4535–4551. doi: 10.7150/thno.25674.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/thno.25674</ArticleId>
            <ArticleId IdType="pmc">PMC6134933</ArticleId>
            <ArticleId IdType="pubmed">30214637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bullón P, Alcocer-Gómez E, Carrión AM, Marín-Aguilar F, Garrido-Maraver J, Román-Malo L, Ruiz-Cabello J, Culic O, Ryffel B, Apetoh L. AMPK phosphorylation modulates pain by activation of NLRP3 Inflammasome. Antioxid Redox Signal. 2016;24(3):157. doi: 10.1089/ars.2014.6120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2014.6120</ArticleId>
            <ArticleId IdType="pmc">PMC4742979</ArticleId>
            <ArticleId IdType="pubmed">26132721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qiu J, Wang M, Zhang J, Cai Q, Lu D, Li Y, Dong Y, Zhao T, Chen H. The neuroprotection of Sinomenine against ischemic stroke in mice by suppressing NLRP3 inflammasome via AMPK signaling. Int Immunopharmacol. 2016;40:492–500. doi: 10.1016/j.intimp.2016.09.024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.intimp.2016.09.024</ArticleId>
            <ArticleId IdType="pubmed">27769021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nguyen H, Zarriello S, Rajani M, Tuazon J, Napoli E, Borlongan CV. Understanding the role of dysfunctional and healthy mitochondria in strokepathology and its treatment. Int J Mol Sci. 2018;19(7):2127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6073421</ArticleId>
            <ArticleId IdType="pubmed">30037107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garrido-Maraver J, Paz MV, Cordero MD, Bautista-Lorite J, Oropesa-Ávila M, de la Mata M, Pavón AD, De LI, Alcocer-Gómez E, Galán F: Critical role of AMP-activated protein kinase in the balance between mitophagy and mitochondrial biogenesis in MELAS disease. Biochim Biophys Acta 2015, 1852(11):2535–2553.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26341273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heid ME, Keyel PA, Kamga C, Shiva S, Watkins SC, Salter RD. Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation. J Immunol. 2013;191(10):5230–5238. doi: 10.4049/jimmunol.1301490.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1301490</ArticleId>
            <ArticleId IdType="pmc">PMC3833073</ArticleId>
            <ArticleId IdType="pubmed">24089192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang SJ, Shao GF, Chen JL, Gong J. The NLRP3 inflammasome: an important driver of neuroinflammation in hemorrhagic stroke. Cell Mol Neurobiol. 2018;38(3):595-603.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28752408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Q, Lv H, Wen Z, Ci X, Peng L. Isoliquiritigenin activates nuclear factor Erythroid-2 related factor 2 to suppress the NOD-like receptor protein 3 Inflammasome and inhibits the NF-κB pathway in macrophages and in acute lung injury. Front Immunol. 2017;8:1518. doi: 10.3389/fimmu.2017.01518.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2017.01518</ArticleId>
            <ArticleId IdType="pmc">PMC5677786</ArticleId>
            <ArticleId IdType="pubmed">29163554</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo C, Xie S, Chi Z, Zhang J, Liu Y, Zhang L, Zheng M, Zhang X, Xia D, Ke Y. Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome. Immunity. 2016;45(4):802–816. doi: 10.1016/j.immuni.2016.09.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2016.09.008</ArticleId>
            <ArticleId IdType="pubmed">27692610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li S, Sun X, Xu L, Sun R, Ma Z, Deng X, Liu B, Fu Q, Qu R, Ma S. Baicalin attenuates in vivo and in vitro hyperglycemia-exacerbated ischemia/reperfusion injury by regulating mitochondrial function in a manner dependent on AMPK. Eur J Pharmacol. 2017;815:118-126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28743390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li CG, Yan L, Mai FY, Shi ZJ, Xu LH, Jing YY, Zha QB, Ouyang DY, He XH. Baicalin inhibits NOD-like receptor family, Pyrin containing domain 3 Inflammasome activation in murine macrophages by augmenting protein kinase a signaling. Front Immunol. 2017;8:1409.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5674921</ArticleId>
            <ArticleId IdType="pubmed">29163487</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
